(Links are from my findings unless otherwise noted: All commentary unquoted commentary is mine)
___________________________________________
At Gallup — “Generic Republican 44%, Obama 39%” (HT Hot Air via Instapundit). This means a sensible, constitution-loving conservative kicks Obama’s butt by double digits.
___________________________________________
(via Greg) At the Washington Times – “Lawmakers sue to end U.S. role in Libya fight”:
By Sept. 30, the end of the fiscal year, that will have grown to $1.1 billion, with an additional $50 million spent on munitions over the final four months.
Obama administration officials said those funds are being shifted from within the Defense Department, and it doesn’t see a need to request emergency funds from Congress.
In other words, likely necessary ordinary defense spending is being cut to fund an unauthorized foreign adventure.
By contrast, Bush 43 got resolutions from Congress before sending troops into Afghanistan and Iraq. Who’s the real warmonger here?
___________________________________________
At the Hill (HT Doug Powers at Michelle Malkin’s place) — “Pelosi’s wealth grows by 62 percent.” It went from “at least” $21.7 mil to “at least” $35.2 mil during 2010. I’ve seen similar forms. The figures are likely much, much lower than the actuals.
Nice work if you can get it. Too bad so many people can’t even find work.
___________________________________________
(via Greg) In a Washington Times editorial — “States challenge feds on guns; Ninth Circuit hears case to nullify federal intrastate firearm regulations.” Specifically:
Eight states have thrown down the gauntlet and denied the federal government’s authority to regulate firearms that never cross state lines.
… The Justice Department wants (wannabe intrastate gunmaker Mr. (Gary S.) Marbut’s lawsuit thrown out and Montana’s firearms-freedom statute nullified.
Greg would like to see Ohio enact a similar law.
Hmm. This would seem to a natural cause for supposedly born-again Second Amendment fan, concealed carry permit holder, and Buckeye State Attorney General Mike DeWine — except that his past includes ringing endorsements from the Brady campaign, and his 2010 campaign position in support of gun rights, including his and Recipe Fran’s permits, were nothing but cynical poses to counteract the consistent pro-gun rights position of his Democratic opponent.
Prove me wrong, Mike.
__________________________________________
From Luba Sindler at American Thinker (HT Confederate Yankee via Greg) — Take it from someone who’s been there, done that, fled that, and is seeing it again (bold is mine):
When candidate Obama showed up, I realized that I had heard his typical stump speech every single day of my old Soviet life from big and small Communist party bosses — the same structure, the same cadences, the same bogeymen, the same demagoguery, the same targets. The American people had no defense against this rhetoric. The result of the elections was totally predictable. To me it was a “Back to the Future” moment.
Imagine you are having a terrible nightmare. Just as you are about to suffer torture or certain death, you wake up and realize the sun is shining, your family is peacefully sleeping, and everything is in place. After enjoying a few blissful moments, you turn your head and see that hideous monster from your dream coming after you for real. This image described the trajectory of my life perfectly. Running from Communism, finding the safe haven and a new life, and now to have the same wrecking crew coming even here?
Yep.
__________________________________________
The FDA as a de facto Death Panel — This is from the Wall Street Journal in mid-April (HT at the end of a maze to Dad29 via Greg):
Shortage Worsens of Leukemia Drug
A shortage of a key leukemia drug that started last year has worsened, causing many major cancer centers such as the Johns Hopkins Hospital to start rationing the drug and others to turn away patients from community hospitals that have run out of the medication.
The three companies that make the drug, called cytarabine, have all suffered production difficulties in the past year. Only one of them, Hospira Inc., is currently shipping the drug, but only in limited quantities that are not nearly enough to meet demand. A shortage in 2010 of the active ingredient used to make cytarabine slowed production at Hospira.
The back story, which the Journal should have told and didn’t, is that FDA, beyond micromanaging manufacturing processes beyond all reason, is actually dictating how much companies can produce, as explained at the Health Affairs blog (bold is mine):
The Federal Food and Drug Administration (FDA) has been stepping up its quality enforcement efforts — levying fines and forcing manufacturers to retool their facilities both here and abroad. Not only has this more rigorous regulatory oversight slowed down production, the FDA’s “zero tolerance” regime is forcing manufacturers to abide by rules that are rigid, inflexible and unforgiving. For example, a drug manufacturer must get approval for how much of a drug it plans to produce, as well as the timeframe. If a shortage develops (because, say, the FDA shuts down a competitor’s plant), a drug manufacturer cannot increase its output of that drug without another round of approvals. Nor can it alter its timetable production (producing a shortage drug earlier than planned) without FDA approval.
My late father worked in the pharmaceutical industry for over 30 years until the mid-1990s and was involved in quality control during that entire time. He talked about the out-of-control FDA a lot, but he never, ever said a word about dictating levels of production.
The FDA is engaging in Soviet-style central planning, with tragically predictable results. The agency’s behavior dates back to Bush 43, but as would be expected, it seems to have ramped upon El Presidente Obama’s arrival. Some people in life-and-death situations are not getting the drugs they need. If Obamacare ever kicks in, “some” will become “most” in relatively short order.